Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HOUSE COMMERCE/OVERSIGHT SUBCOMMITTEE COUNSEL PATRICK McLAIN

Executive Summary

HOUSE COMMERCE/OVERSIGHT SUBCOMMITTEE COUNSEL PATRICK McLAIN is leaving Capitol Hill in February to become Senior VP of the Washington, D.C. management consultant firm Rowan & Blewitt. McLain served on the staff of Rep. Dingell's (D-Mich.) subcommittee for nearly 14 years. As subcommittee counsel, he was involved in several investigations related to the pharmaceutical industry, including oversight of FDA review of the AIDS products Virazole (by ICN subsidiary Viratek) and Imreg's Imreg-1. McLain also has been active in investigations of FDA's regulation of prescription drug advertising, health claims for food products, Rx-to-OTC switches, and the OTC Review.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS014764

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel